StackLeaf
← Back to feed
VERIFIEDMint Companies·neutral

Delhi HC directs Sun Pharma to take permission before launching semaglutide

AI Summary
  • ·Delhi High Court ordered Sun Pharma to seek judicial approval before launching semaglutide tablets.
  • ·The directive follows a patent infringement suit filed by Novo Nordisk.
  • ·Sun Pharma must return to court after obtaining a manufacturing license.
SUNPHARMA
Read original →